SAlicylaldehyde thiosemicarbazone palladium(II) chloride

Catalog No. :
ACJGOE279
CAS No. :
219954-63-9
Molecular Formula :
C8H9Cl2N3OPdS
Molecular Weight :
372.57

IUPAC Name:-

SAlicylaldehyde thiosemicarbazone palladium(II) chloride structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g98%$145.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameSAlicylaldehyde thiosemicarbazone palladium(II) chloride
MDL No.-
Molecular FormulaC8H9Cl2N3OPdS
Molecular Weight372.57
SMILESNC(=S)N/N=C/C1=CC=CC=C1O.[Cl-].[Cl-].[Pd+2]
InChI KeyPZHXJLUMWROTOU-RWWJYAHQSA-L
SynonymSALICYLALDEHYDE THIOSEMICARBAZONE PALLADIUM(II) CHLORIDE, 97%;Salicylaldehyde thiosemicarbazone palladium(II) chloride 97%;Salicylaldehyde thioseMicarbazone palladiuM(II) chloride,97%;Palladium,chloro[2-[[2-(hydroxy-kO)phenyl]methylene]hydrazinecarbothioamidato-kN2,kS]-, (SP-4-4)-;Palladium,chloro[2-[[2-(hydroxy-kO)phenyl]methylene]hydrazin...;Palladium(II) (E)-2-(2-oxidobenzylidene)hydrazine-1-carbimidothioate hydrochloride;Salicylaldehyde thiosemicarbazone palladium(II) chloride, CAS 219954-63-9;SALICYLALDEHYDE THIOSEMICARBAZONE PALLADIUM(II) CHLORIDE, 97%
CAS No.219954-63-9

Safety Data

Pictogram
Toxic
Signal Word
Danger
Hazard Statement(s)
H301-H311-H331
Precautionary Statement(s)
P261-P280-P301+P310-P311

Synthetic Route by SureRoute

1. ACJGOE279 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACJGOE279 route product structure diagram
    ACJGOE279219954-63-9
Inquiry

2. ACJGOE279 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACJGOE279 route product structure diagram
    ACJGOE279219954-63-9
Inquiry

Comments (0)